Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-03

Clinical Trial Update: Levodopa for Diabetic Retinopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating levodopa for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • levodopa (levodopa)

Snippet

Sponsor: Emory University | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED